APA (7th ed.) Citation

Cheng, F., Peng, L., & Luo, D. (2022). Methyltransferase‐like 3 promotes the progression of lung cancer via activating PI3K/AKT/mTOR pathway. Clinical & Experimental Pharmacology & Physiology, 49(7), 748. https://doi.org/10.1111/1440-1681.13647

Chicago Style (17th ed.) Citation

Cheng, Feng‐Wu, Li‐Ming Peng, and Dan Luo. "Methyltransferase‐like 3 Promotes the Progression of Lung Cancer via Activating PI3K/AKT/mTOR Pathway." Clinical & Experimental Pharmacology & Physiology 49, no. 7 (2022): 748. https://doi.org/10.1111/1440-1681.13647.

MLA (9th ed.) Citation

Cheng, Feng‐Wu, et al. "Methyltransferase‐like 3 Promotes the Progression of Lung Cancer via Activating PI3K/AKT/mTOR Pathway." Clinical & Experimental Pharmacology & Physiology, vol. 49, no. 7, 2022, p. 748, https://doi.org/10.1111/1440-1681.13647.